Lack of p53 protein expression in preneoplastic rat hepatocytes in vitro after exposure to N-acetoxy-acetylaminofluorene, X-rays or a proteasome inhibitor

European Journal of Cancer

Volumn 36, Issue 1, 2000, Pages 106-112

  Van Gijssel, H E ^a   Stenius, U ^b   Mulder, G J ^a   Meerman, J H N ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Carcinogenesis; Clonal expansion; DNA damage; p53; Preneoplastic heptatocytes; X rays

Indexed keywords

N ACETOXY N (2 FLUORENYL)ACETAMIDE; PROTEASOME INHIBITOR; PROTEIN P53;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CARCINOGENESIS; CELL CYCLE; CELL SURVIVAL; CONTROLLED STUDY; DNA DAMAGE; FEMALE; LIVER CELL; NONHUMAN; PRECANCER; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RAT; X RAY;

EID: 0033958415     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(99)00239-7     Document Type: Article

References (36)

1. Dragan Y.P., Campbell H.A., Xu X.H., Pitot H.C. Quantitative stereological studies of a 'selection' protocol of hepatocarcinogenesis following initiation in neonatal male and female rats. Carcinogenesis. 18:1997;149-158.
2. Solt D.B., Farber E. New principle for the analysis of chemical carcinogenesis. Nature. 263:1976;701-703.
3. Farber E. Clonal adaptation during carcinogenesis. Biochem. Pharmacol. 39:1990;1837-1846.
4. Ko L.J., Prives C. p53 puzzle and paradigm. Genes Dev. 10:1996;1054-1072.
5. Choisy-Rossi C., Yonish-Rouach E. Apoptosis and the cell cycle. the p53 connection Cell Death Different. 5:1998;129-131.
6. Fritsche M., Haessler C., Brandner G. Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents. Oncogene. 8:1993;307-318.
7. Kastan M.B., Onyekwere O., Sidransky D., Vogelstein B., Craig R.W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51:1991;6304-6311.
8. Zhan Q., Carrier F., Fornace J.R. Induction of cellular p53 activity by DNA damaging agents and growth arrest. Mol. Cell. Biol. 13:1993;4242-4250.
9. Chiarugi V., Cinelli M., Magnelli L. Acetylation and phosphorylation of the carboxy-terminal domain of p53. regulative significance Oncol. Res. 10:1998;55-57.
10. van Gijssel H.E., Maassen C.B.M., Mulder G.J., Meerman J.H.N. p53 protein expression by hepatocarcinogens in the rat liver and its potential role in mitoinhibition of normal hepatocytes as a mechanism of hepatic tumour promotion. Carcinogenesis. 18:1997;1027-1033.
11. Stenius U., Högberg J. GST-P-positive hepatocytes isolated from rats bearing enzyme-altered foci show no signs of p53 protein induction and replicate even when their DNA contains strand breaks. Carcinogenesis. 16:1995;1683-1686.
12. Lennartsson P., Högberg J., Stenius U. Wild-type p53 expression in liver tissue and in enzyme-altered foci. an in vivo investigation on diethylnitrosamine-treated rats Carcinogenesis. 19:1998;1231-1237.
13. Kubbutat M.H.G., Jones S.N., Vousden K.H. Regulation of p53 stability by Mdm2. Nature. 387:1997;299-303.
14. Haupt Y., Maya R., Kazaz A., Oren M. Mdm2 promotes the rapid degradation of p53. Nature. 387:1997;296-299.
15. Ringer D.P., Norton T.R. Further characterization of the ability of hepatocarcinogens to lower rat liver aryl sulfotransferase activity. Carcinogenesis. 8:1987;1749-1752.
16. Degawa M., Miura S., Hashimoto Y. Expression and induction of cytochrome P450 enzymes in hyperplastic nodules of rat liver. Carcinogenesis. 12:1991;2151-2156.
17. Gazos Lopes U., Erhardt P., Yao R., Cooper G.M. p53-dependent induction of apoptosis by proteasome inhibitors. J. Biol. Chem. 272:1997;12893-12896.
18. Beland F.A., Dooley K.L., Casciano D.A. Rapid isolation of carcinogen-bound DNA and RNA by hydroxyapatite chromatography. J. Chromatogr. 174:1979;177-186.
19. Stenius U., Warholm M., Martens U., Högberg J. Isolation of glutathione-S-transferase P-positive hepatocytes from carcinogen-treated rats by use of ethacrynic acid as selecting agent. Carcinogenesis. 15:1994;1561-1566.
20. Lii C.K., Wang S.T., Chen H.W., Sheen L.Y. Glutathione and glutathione-related enzyme activities of male and female rat hepatocytes under various culture condtions. Arch. Toxicol. 70:1996;822-829.
21. van Gijssel H.E., van Gijlswijk R.P.M., de Haas R.R., Stark C., Mulder G.J., Meerman J.H.N. Immunohistochemical visualization of wild-type p53 protein in paraffin-embedded rat liver using tyramide amplification. zonal hepatic distribution of p53 protein after N-hydroxy-acetylaminofluorene administration Carcinogenesis. 19:1998;219-222.
22. MacCullum D.E., Hupp T.R., Midgley C.A.et al. The p53 response to ionising radiation in adult and developing murine tissues. Oncogene. 13:1996;2575-2587.
23. Tates A.D., Neuteboom I., Rotteveel A.H.M., de Vogel N., Menkveld G.J., den Engelse L. Persistence of preclastogenic damage in hepatocytes of rats exposed to ethylnitrosourea, diethylnitrosamine, dimethylnitrosamine, and methyl methanesulphonate. Correlation with DNA O-alkylation. Carcinogenesis. 7:1986;1053-1058.
24. Fausto N., Mead J.E. Biology of disease, regulation of liver growth. protooncogenes and transforming growth factors Lab. Invest. 60:1989;4-13.
25. Komarova E.A., Zelnick C.R., Chin D.et al. Intracellular localization of p53 tumor supressor protein in γ-irradiated cells is cell cycle regulated and determined by the nucleus. Cancer Res. 57:1997;5217-5220.
26. Brown J.P., Pagano M. Mechanism of p53 degradation. Biochim. Biophys. Acta. 1332:1997;O1-O6.
27. Wang X., Matsumoto H., Okaichi K., Ohnishi T. p53 accumulation in various organs of rats after whole-body exposure to low-dose X-ray irradiation. Anticancer Res. 16:1996;1671-1674.
28. van den Goorbergh J.A.M., Meerman J.H.N., de Wit H., Mulder G.J. Reaction of 2-acetylaminofluorene-N-sulfate with RNA and glutathione. evidence for generation of two reactive intermediates with different reactivities towards RNA and glutathione Carcinogenesis. 6:1985;1635-1640.
29. Meerman J.H.N., Tijdens R.B. Effect of glutathione depletion on the hepatotoxicity and covalent binding to rat liver macromolecules of N-hydroxy-2-acetylaminofluorene. Cancer Res. 45:1985;1132-1139.
30. Newman H.C., Prise K.M., Folkard M., Michael B.D. DNA double strand break distributions in X-ray and alpha-particle irradiated V79 cells. evidence for non-random breakage Int. J. Radiat. Biol. 71:1997;347-363.
31. Schulte-Hermann R., Timmermann-Trosiener I., Barthel G., Bursch W. DNA synthesis, apoptosis, and phenotypic expression as determinants of growth of altered foci in rat liver during phenobarbital promotion. Cancer Res. 50:1990;5127-5135.
32. Stinchcombe S., Buchmann A., Bock K.W., Schwarz M. Inhibition of apoptosis during 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated tumour promotion in rat liver. Carcinogenesis. 16:1995;1271-1275.
33. Grasl-Kraupp B, Ruttkay-Nedecky B, et al. Inherent increase of apoptosis in liver tumors: implications for carcinogenesis and tumor regression. Hepatology 25, 906-912.
34. Schulte-Hermann R., Bursch W., Löw-Baselli A., Wagner A., Grasl-Kraupp B. Apoptosis in the liver and its role in hepatocarcinogenesis. Cell Biol. Toxicol. 13:1997;339-348.
35. Tatematsu M., Aoki T., Kagawa M., Mera Y., Ito N. Reciprocal relationship between development of glutathione S-transferase positive liver foci and proliferation of surrounding hepatocytes in rats. Carcinogenesis. 9:1988;221-225.
36. Griffiths S.D., Clarke A.R., Ross G.et al. Absence of p53 permits propagation of mutant cells following genotoxic damage. Oncogene. 14:1997;523-531.